PLAUR and neoplasm: Hu et al. also developed anti-uPAR antibody and indocyanine green (ICG)-modifed gold nanoshells (uIGNs), and achieved a 25% higher median survival rate and complete tumour ablation than clinical iodine-125 (125I) interstitial brachy-therapy (IBT-125-I).